Eterna Therapeutics Inc. Annual Share-based Payment Arrangement, Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Eterna Therapeutics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
  • Eterna Therapeutics Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $423K, a 97.7% increase year-over-year.
  • Eterna Therapeutics Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $1.04M, a 41.2% decline year-over-year.
  • Eterna Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.24M, a 57.7% decline from 2022.
  • Eterna Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.94M, a 43.9% decline from 2021.
  • Eterna Therapeutics Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.24M, a 5653% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.24M -$1.69M -57.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $2.94M -$2.3M -43.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $5.24M +$5.14M +5653% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 $91K Jan 1, 2020 Dec 31, 2020 10-K/A 2022-07-01
2013 $132K -$53K -28.6% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-31
2012 $185K Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.